Literature DB >> 3888988

Protein synthesis in rabbit reticulocytes. Purification and properties of an Mr 80,000 polypeptide (Co-eIF-2A80) with Co-eIF-2A activity.

I Chakravarty, M K Bagchi, R Roy, A C Banerjee, N K Gupta.   

Abstract

The high molecular weight protein complex, Co-eIF-2, contains both Co-eIF-2A and Co-eIF-2C activities (Bagchi, M. K., Banerjee, A. C., Roy, R., Chakravarty, I., and Gupta, N. K. (1982) Nucleic Acids Res. 10, 6501-6510). Co-eIF-2A stimulated Met-tRNAf binding to eukaryotic initiation factor-2 (eIF-2) both in the presence and absence of Mg2+. Co-eIF-2C stimulates Met-tRNAf binding to eIF-2 in the presence of Mg2+ by relieving Mg2+ inhibition of ternary complex formation from eIF-2. Co-eIF-2 protein complex contains several polypeptides including Mr 80,000 and 50,000 polypeptides. Three polypeptides (Mr 80,000, 50,000 and 25,000) are present in 0.5 M KCl ribosomal salt wash and each possesses Co-eIF-2A activity. Mr 80,000 polypeptide (Co-eIF-2A80) has been purified to homogeneity and its properties studied. 1) Co-eIF-2A80 stimulated Met-tRNAf binding to eIF-2 and the complex formed was resistant to aurintricarboxylic acid. 2) Co-eIF-2A80 activity was N-ethylmaleimide-resistant and heat-labile; it was destroyed by heating at 55 degrees C for 4 min. 3) Antibodies prepared against homogeneous Co-eIF-2A80 strongly inhibited protein synthesis in reticulocyte lysates and, also, eIF-2 and Co-eIF-2 promoted Met-tRNAf binding to 40 S ribosomes. Inhibition of protein synthesis in reticulocyte lysates was overcome by preincubation of anti-Co-eIF-2A80 with homogeneous Co-eIF-2A80 and was partially overcome by similar preincubation with Co-eIF-2. 4) Upon limited digestion with Staphylococcus aureus V8 protease, the homogeneous Co-eIF-2A80 gave two major polypeptide fragments (Mr 50,000 and 25,000). Upon similar treatment, an Mr 80,000 polypeptide band isolated from the sodium dodecyl sulfate-gel of the Co-eIF-2 protein complex gave four major polypeptide fragments, and two of these fragments (Mr 50,000 and 25,000) were similar to those given by Co-eIF-2A80, indicating that this Mr 80,000 polypeptide band contains the Co-eIF-2A80 component. We suggest that Co-eIF-2A80 is a component of Co-eIF-2 and is also essential for Co-eIF-2 activity and overall peptide chain initiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3888988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  MicroRNA-repressed mRNAs contain 40S but not 60S components.

Authors:  Bingbing Wang; Adrienne Yanez; Carl D Novina
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-04       Impact factor: 11.205

2.  Mechanism of peptide chain initiation in animal cells: a reevaluation.

Authors:  N K Gupta; D Chakrabarti
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

3.  GERp95, a membrane-associated protein that belongs to a family of proteins involved in stem cell differentiation.

Authors:  D E Cikaluk; N Tahbaz; L C Hendricks; G E DiMattia; D Hansen; D Pilgrim; T C Hobman
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

4.  miRNA repression of translation in vitro takes place during 43S ribosomal scanning.

Authors:  Emiliano P Ricci; Taran Limousin; Ricardo Soto-Rifo; Paulina S Rubilar; Didier Decimo; Théophile Ohlmann
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

5.  Activation of a microRNA response in trans reveals a new role for poly(A) in translational repression.

Authors:  Emiliano P Ricci; Taran Limousin; Ricardo Soto-Rifo; Rachel Allison; Tuija Pöyry; Didier Decimo; Richard J Jackson; Théophile Ohlmann
Journal:  Nucleic Acids Res       Date:  2011-03-08       Impact factor: 16.971

6.  A conserved PUF-Ago-eEF1A complex attenuates translation elongation.

Authors:  Kyle Friend; Zachary T Campbell; Amy Cooke; Peggy Kroll-Conner; Marvin P Wickens; Judith Kimble
Journal:  Nat Struct Mol Biol       Date:  2012-01-08       Impact factor: 15.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.